Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Angela Guo is a high school student from Hong Kong currently studying at Phillips Academy Andover. She has spent the past year researching the impacts of nuclear testing on the Marshall Islands and recently published her first book, “At the Tide’s Mercy: Voices from the Marshallese Exodus”.
Innovation Enables Responsibility: Watermarking to Strengthen DNA Synthesis Screening
The development of SynthID Bio by a major frontier AI lab is an important reminder that responsible development and cutting-edge progress are not mutually exclusive.
NTI at 25: Fostering Innovation Through Technology Governance
As NTI celebrates 25 years of impact, we remain committed to reducing the risks of accidental release and deliberate misuse of life science innovations, strengthening global biosecurity, and guiding efforts to govern emerging technologies.
People Are Trying to Misuse AI. That’s Exactly Why Safeguards Matter.
The policy challenge ahead is ensuring that safeguards, governance frameworks, and security practices continue to responsibly scale alongside the technology. If they do, society can capture AI's enormous benefits while keeping emerging risks firmly under control.
AI Can Design New Proteins. It’s Time to Build Real Biosecurity Guardrails
As protein design tools and other biological AI models become more capable of designing novel biological components and systems, the mechanisms to prevent misuse have not kept pace.
A Simple Step to Close a Dangerous Biosecurity Gap
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.
Why Responsible AIxBio Innovation Must Be on New Delhi’s Agenda
Some of the world’s largest AI companies—Google DeepMind, OpenAI, and Anthropic—have warned that their models could be misused to cause harm with biology. The India AI Impact Summit is a critical moment for policymakers, scientists, developers, and biosecurity experts to work together on responsible governance that reduces AIxBio risks.
The AI-biology convergence offers enormous benefits but also brings about risks as we’ve never seen before. Without action from multiple disciplines, the race for AI development and dominance could become a race to the bottom when it comes to safety and security.
Innovation requires security, and security requires innovation. Congress needs to act decisively to ensure U.S. leadership in biotechnology is paired with governance that keeps its development secure.